Both in vitro and in vivo experiments have implicated extracellular glycine in the pathogenesis of ischemic brain damage. Recently, halogenated deriva tives of quinoxaline-2,3-dione have been synthesized that possess bioavailability when parenterally administered and minimal psychotomimetic properties. Such com pounds have allowed investigation into the efficacy of glycine receptor antagonism as a strategy for protection against cerebral ischemic insults. Rats underwent either 90 min of middle cerebral artery filament occlusion or lO min of forebrain ischemia with recovery while receiving intraperitoneal injections of either a glycine receptor an tagonist (ACEA-I021, ACEA-1031, or ACEA-lOll) or vehicle (dimethyl sulfoxide). Both ACEA-I021 and
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That study, however, also demonstrated that doses of the drug must be severely limited because of prevalent psychotomimetic side effects associated with larger (and potentially more cerebroprotective)
doses.
An alternative pharmacologic target for antago nism of glutamatergic excitotoxicity is the glycine recognition site of the NMDA receptor complex.
Glycine is required to coactivate the NMDA recep tor before the associated ionophore becomes per meable to calcium (Dalkara et aI., 1992; Forsythe et aI., 1988; Lester et aI., 1993) . Glycine has also been demonstrated to be required in cell culture medium to allow glutamate toxicity in cultured .neurons (J ohnson and Ascher, 1987) . Further, interstitial glycine concentrations become substantially in creased during an ischemic insult and remain ele-vated for prolonged intervals after reperfusion (Baker et aI., 1991; Globus et aI., 1991) .
Recently, a family of highly specific strychnine insensitive glycine receptor antagonists have been synthesized by halogen substitutions on the basic quinoxaline-2,3-dione structure (Cai et al., 1993) (see Fig. 1 ). These compounds are believed to cross the blood-brain barrier effectively, as demonstrated by inhibition of electroshock seizures, and appear to have minimal phencyclidine-like side effects when evaluated by drug substitution assays in con ditioned rats (Balster et aI., 1993) . Accordingly, we examined the effects of administration of three dif ferent quinoxalinedione derivatives in rodent mod els of both focal and global ischemia.
METHODS
The following studies were approved by the University of Iowa Animal Care and Use Committee. The two models are described first, followed by the experimental protocols.
Focal ischemia model
Fasted male Wistar rats (body weight range 275-330 g; Harlan, Indianapolis, IN, U.S.A.) were anesthetized with halothane in 40% Oz/balance N2 and allowed to breathe spontaneously with the anesthetic agent delivered via a snout cone. The tail artery was catheterized via surgical incisions and the bifurcation of the right common carotid artery was identified and isolated. The internal carotid artery was traced distally until the pterygopalatine artery was visualized. The external carotid artery was ligated and bisected.
A surgical preparation interval of 40 min was followed by a 15-min interval for physiologic stabilization before onset of ischemia. During this interval, pericranial tem perature was servoregulated to 38.0::!: O.loC from a 22-g needle thermistor (Yellow Springs Instruments Model 524, Yellow Springs, OH, U.S.A.) percutaneously posi tioned adjacent to the skull. Heparin (50 IU) was admin- istered via the arterial catheter. Blood samples for plasma glucose, Pa02, PaCOZ' arterial pH, and hematocrit mea surement were obtained 5 min before onset of ischemia. In addition, 0.5 ml of arterial blood was taken for later high-performance liquid chromatography (HPLC) mea surement of plasma glycine receptor antagonist concen tration by ACEA Pharmaceuticals (Irvine, CA, U.S.A.). Ischemia was induced in all rats by a modification of the techniques previously described (Memezawa et aI., 1992; Zea Longa et aI., 1989) . A 0.25-mm diameter nylon monofilament (Platil, West Germany) was inserted -23 mm into the internal carotid artery via the proximal ex ternal carotid stump thereby occluding the middle cere bral artery. Immediately after filament insertion, the wound was loosely closed and the rats were allowed to awaken. Time to recovery of righting reflex was typically <5 min.
The rats were then placed in an oxygen enriched envi ronment (F102 = 40%) for -85 min. Mean arterial blood pressure was continuously monitored during this period. At 5-min intervals rectal temperature was determined. After 90-min ischemia, the rats were rapidly reanesthe tized with halothane. The occlusive filament was with drawn allowing reperfusion of the carotid artery and its distal branches. The arterial catheter was removed and the wounds closed with suture. The animals were then awakened and placed in an oxygen-enriched environment for -90 min. Rats were then returned to their cages for a survival interval of 96 h.
At 24 and 96 h after reperfusion the rats were evaluated neurologically, using a 4-point scale with the observer blinded to group assignment (Bederson et aI., 1986) : Grade 0: no observable deficit; Grade 1: forelimb flexion; Grade 2: decreased resistance to lateral push (and fore limb flexion) without circling; Grade 3: same behavior as grade 2, with circling.
After final neurologic evaluation, the rats were killed by a halothane overdose. The brains were excised and frozen in -50°C 2-methyl butane. Using a cryotome, qua druplicate 20-f-Lm thick coronal sections were taken at 360-f-Lm intervals over the rostral-caudal extent of the infarct. The sections were dried and stained for -30 min with a solution containing 4.052 g sodium succinate and 0.135 g nitro blue tetrazolium (Sigma Chemical Co., St Louis, MO, U.S.A.) dissolved in 300 ml buffered distilled water (pH = 7.2; 30°C). Infarct volumes were measured by an observer blinded to experimental group assignment using established image analysis techniques (Warner et aI., 1993) .
Cerebral infarct volumes, glycine receptor antagonist plasma concentrations, and intraischemia (45 min) rectal temperatures were compared by one way analysis of vari ance (ANOV A). When indicated, between-group differ ences were determined by Fisher's protected least significant difference (PLSD) test. Other physiologic val ues were compared qualitatively to preserve statistical power. Neurologic grades were compared between groups by the Kruskal-Wallis H statistic. Correlations between infarct volumes and neurologic grades were as sessed by the Spearman rank sum coefficient. Parametric values are reported as mean::!: standard deviation; p < 0.05 was considered significant.
Forebrain ischemia model
Male Sprague-Dawley rats (both weight range 275-325 g; Harlan, Indianapolis, IN, U.S.A.) were fasted from food for 12-16 h before the experiment, anesthetized with halothane, and surgically prepared for two-vessel occlu sion forebrain ischemia, as previously described (Gionet et aI., 1992) .
A surgical preparation interval of 35 min was followed by a 30-min interval for physiologic stabilization before onset of ischemia. Blood samples for plasma glucose, Pao2, Paco2, arterial pH, and hematocrit measurement were obtained 5 min before onset of ischemia. In addi tion, 0.5 ml of arterial blood was taken for later HPLC determination of plasma glycine receptor antagonist con centnition.
The protocol for producing forebrain ischemia was the same for all animals (Gionet et aI., 1992; Smith et aI., 1984) . Hypotension (MABP = 30 ± 5 mm Hg) was in duced with i. v. trimethaphan (1. 75 mg) and maintained by withdrawal of blood through the jugular catheter as nec essary. Immediately after onset of hypotension, the ca rotid arteries were occluded bilaterally. Onset and main tenance of EEG isoelectricity was documented. Ten min utes later, the vascular clamps were released, any shed blood was reinfused, and 0.27 mEq NaHC03 was given to minimize systemic acidosis. The catheters were removed and incision sites closed with suture. Twenty minutes fol lowing the ischemic insult, halothane anesthesia was dis continued and the animals were awakened. After recov ery of spontaneous ventilation, the tracheas were extu bated. Rats were then placed in a chamber containing 50% O2/50% N2 until the righting reflex recovered. The animals were returned to their cages for a 5-day recovery interval.
Motor function tests were performed 5 days post ischemia according to established techniques (Combs and D'Alecy, 1987; Gionet et aI., 1991) . From these three tests, a total motor score (9 possible points) was com puted. After neurologic testing, rats were anesthetized with halothane and the brains were perfusion-fixed in situ with buffered 4% formalin (pH 7.35). The brains were allowed to stabilize overnight before removal and storage in 4% formalin. Paraffin-embedded brain sections were serially cut (5-fLm thickness) and stained with celestine blue/acid fuchsin (Auer et aI., 1984) . Injury in the hippo campal CAL sector, neocortex, and caudoputamen was assessed by an investigator blind to group membership. Viable and nonviable neurons within the pyramidal cell layer of CAL were counted from two sections represent ing bregma -3.3 and -3.8 mm. At the level where the septal nuclei were at their widest, damage in the neo cortex and dorsolateral caudoputamen was graded (crude damage index) on a 0--4 scale (0 = no observed histologic changes; 1 = 1-5% neurons with pathologic changes; 2 = 6--50% neurons damaged; and 3 = 51-100% of neurons damaged; 4 = infarction) (Lundgren et aI., 1991) .
Physiologic values and glycine receptor antagonist plasma concentrations were compared by one-way ANOV A. When indicated, between-group differences were identified by the Fisher protected least squares dif ference test. Nonparametric neurologic scores and histo logic values were compared between groups by the Kruskal-Wallis H statistic. Parametric values are re ported as mean ± standard deviation; p < 0.05 was con sidered significant.
Experiment one
ACEA-1021 was administered to rats undergoing focal ischemia. Rats were assigned to one of three groups by J Cereb Blood Flow Metab, Vol. 15, No.2, 1995 chance (n = 9 per group). Group I (vehicle): DMSO (Sigma Chemical Co., St Louis, MO, U.S.A.) i.p. only (l ml/kg); Group II: ACEA-1021 10 mg/kg i.p. dissolved in DMSO (total volume = 1 mllkg); Group III: ACEA-1021 30 mg/kg i.p. dissolved in DMSO (total volume = 1 ml/ kg).
Respective injections for each of the three groups were given 55 min before onset of ischemia, at termination of ischemia, and at 180 min after reperfusion.
Experiment two
ACEA-1031 was administered to rats undergoing focal ischemia. Rats were assigned to one of three groups by chance (n = 11-13 per group). Group I (vehicle): DMSO i.p. only (l ml/kg); Group II: ACEA-1031 10 mg/kg i.p. dissolved in DMSO (total volume = 1 mllkg); Group III: ACEA-1031 30 mg/kg i.p. dissolved in DMSO (total vol ume = 1 ml/kg).
Experiment three
ACEA-1011 was administered to rats undergoing focal ischemia. Rats were assigned to one of two groups by chance (n = 10 per group). Group I (vehicle): DMSO i.p. only (l mllkg); Group II: ACEA-I011 3 mg/kg i.p. dis solved in DMSO (total volume = 1 mllkg).
Experiment four
ACEA-1021 was administered to rats undergoing fore brain ischemia. Rats were assigned to one of three groups by chance (n = 12 per group). Group I (vehicle): DMSO i.p. only (l ml/kg); Group II: ACEA-I021 10 mg/kg i.p. dissolved in DMSO (total volume = 1 mllkg); Group III: ACEA-1021 30 mg/kg i.p. dissolved in DMSO (total vol ume = 1 mllkg).
Respective injections for each of the three groups were given 55 min before onset of ischemia and at 25 and 180 min postischemia.
Experiment five
ACEA-1031 was administered to rats undergoing fore brain ischemia. Rats were assigned to one of three groups by chance (n = 12 per group). Group I (vehicle): DMSO only (1 ml/kg); Group II: ACEA-I031 10 mg/kg i.p. dis solved in DMSO (total volume = 1 mllkg); Group III: ACEA-1031 30 mg/kg i.p. dissolved in DMSO (total vol ume = 1 mIlkg).
RESULTS

Experiment 1 (focal ischemia/ACEA-I021)
Physiologic values were similar between groups and are presented in Table I . Plasma concentrations of ACEA-I021 corresponded to increasing adminis tered doses. Although not specifically quantitated, little or no sedation was observed in the drug treated animals in the recovery interval. Rectal tem- perature values as a function of ischemic and reper fusion intervals are given in Fig. 2A Rectal temperature values as a function of ischemic and reperfusion intervals are given in Fig. 2B . Val ues at 45 min after onset of ischemia were different between groups (vehicle = 38. 7 ± 0.6°C; 10 mg/kg = 37.5 ± 0.8OC; 30 mg/kg = 37.0 ± 0.7°C; p < 0. 0 1).
Improved neurologic grades were observed in the treatment groups at 96 h postischemia only (H = 6.44; p = 0.04). Values for cerebral infarct volumes are depicted in Fig. 3B . A main effect for treatment groups was observed in the cortex (vehicle = 205 ± l37 mm 3 ; 10 mg/kg = 85 ± 103 mm 3 ; 30 mg/kg = 80 ± 118 mm 3 ; p = 0.03). Post hoc analysis revealed significant differences between either treatment group and vehicle (p < 0.05). No difference was evident between treatment groups. Infarct volume was also different between groups in the subcortical region (vehicle = l32 ± 54 mm 3 ; 10 mg/kg = 108 ± 41 mm 3 ; 30 mg/kg = 72 ± 42 mm 3 ; p = 0.01).
Linear regression analysis revealed an association
between increased rectal temperature at 45 min af ter onset of ischemia and greater cortical, subcorti cal, and total infarct volumes (p < 0.01).
Experiment 3 (focal ischemia/ACEA-IOll)
Physiologic values were essentially the same as for experiment 1 and therefore are not depicted. observed in the drug-treated animals. Rectal tem perature values are given in Fig. 2C mained obtunded for 30-60 min after discontinua tion of halothane anesthesia.
No significant differences between groups were observed in neurologic function at 5 days post ischemia with 33 of 35 rats achieving a total motor score of 8 or 9. Moderate hippocampal injury was present in all three groups, with no differences be tween groups for percentage of dead CAl neurons (e.g. , bregma -3.3 mm: vehicle = 59 ± 27%; 10 mg/kg = 59 ± 29%; 30 mg/kg = 65 ± 30%; p = 0.85). Although damage to the neocortex and dor solateral caudoputamen occurred, no difference be tween groups was observed for the crude damage index in either structure (cortex: H = 1.59, p 0.45; caudoputamen: H = 1. 95; p = 0.38).
Experiment 5 (forebrain ischemia/ACEA-I031)
Twelve rats entered the surgical protocol in each of the three groups. Five rats in the ACEA-1031 30 mg/kg group died 1-2 days postischemia. These rats typically demonstrated heavy sedation after isch emia. Although withdrawal from noxious stimuli was observed and recovery of spontaneous ventila tion occurred, these animals remained obtunded for several hours with loss of righting reflex. Those rats destined to die failed to recover feeding and groom ing behavior. Evidence for postischemic seizures was absent. Neither intracranial nor intraperitoneal hemorrhage was evident at necropsy. The differ ence in mortality rates between the ACEA-1031 30 mg/kg group and the vehicle groups was significant (Fisher exact test p = 0.04). The sedative effect of ACEA-1031 10 mg/kg was markedly reduced from that observed in the 30 mg/kg group, and no deaths occurred. Vehicle-treated animals recovered rap-idly from anesthesia and had regained the righting reflex within 30-40 min after reperfusion.
Physiologic values for experiment 5 were similar to those observed in experiment 4 and therefore are not depicted. No significant differences between groups were observed in neurologic function at 5 days postischemia (p = 0.08). Twenty-eight of the 31 surviving rats achieved a total motor score of 8 or 9. Moderate hippocampal injury was present in all three groups with no differences between groups for percentage of dead CAl neurons (e. g., bregma -3.3 mm: vehicle = 49 ± 27%; ACEA-1031 10 mg/ kg = 48 ± 27%; ACEA-1031 30 mg/kg = 50 ± 26%; p = 0.98). Although damage to the neocortex and dorsolateral caudoputamen occurred, no difference between groups was observed for the crude damage index in either structure (cortex: H = 4.3, p = 0. 12; caudoputamen: H = 3.7; p = 0.16). A small degree of AMP A receptor antagonism has been reported for ACEA-1021 in addition to its effects at the glycine recognition site (Woodward et aI. , 1993) . Previous studies, using similar models of forebrain ischemia have reported a reduction in se lective neuronal necrosis in rats treated with AMP A receptor antagonists (Buchan et aI. , 1991; Diemer et aI., 1992; Nellgard and Wieloch, 1992) . Despite this, any AMP A receptor antagonism elicited by the gly cine receptor antagonists administered in this ex periment was insufficient to appreciably alter out come. Of note, no enhancement of injury was ob served with either compound in surviving rats, although an increased mortality was observed in those animals receiving the largest dose of ACEA-1031 for unknown reasons. There is one methodologic consideration regard ing the filament occlusion model. This model was adopted to minimize any potential confounding be tween anesthetic agents and selective glycine recep tor antagonism. Indeed, animals retained the right ing reflex for �85 min of the 90-min ischemic inter val. Nevertheless, monitoring and control of brain temperature in an awake rat is not straightforward, and there is concern that inhibition of the hyper thermic response to ischemia observed in the con trol groups was contributory to the reduction of in farct volume. Recent work has demonstrated that a sustained increase of pericranial temperature by MCA filament occlusion causes a substantial in crease in infarct volume (Warner et aI. , 1993) . For this reason, and because only rectal temperature was monitored in the current experiment, additional work is planned to define the role of temperature in the reduction of infarct volume observed for ACEA-102 1.
DISCUSSION
One piece of evidence, however, leads us to be lieve that glycine receptor antagonism causes direct cytoprotection. In experiment 3, rats were admin istered an analog, ACEA-lOll. For unexplained reasons, large doses of the drug were toxic, and thus the maximal dose studied was lIl0th that stud ied for the other two compounds. Despite this, the hyperthermic response to ischemia was attenuated ( Fig. lC ), yet no reduction in infarct volume was observed.
Other investigators have evaluated the role of the strychnine-insensitive glycine receptor in models of both in vitro and in vivo neurodegeneration. Priest ley et al. (1990) observed a reduction of lactate de hydrogenase release in hypoxic neuronal cultures treated with 7-chlorokynurenic acid, which was of a magnitude comparable to that produced by treat ment with MK-80l. In vivo, an intraperitoneal in jection of 7-chlorokynurenic acid produced a 52% reduction in brain necrosis resulting from intrastri atal injections of NMDA but not quisqualate, con sistent with NMDA receptor glycine recognition site specificity for the antagonist (McDonald et aI., 1989) . Using a hippocampal slice preparation, Wal lis and Panizzon (1993) found reversal of hypoxic protection by the partial glycine antagonist felbam ate when the perfusate contained glycine. Finally, Wood et al. (1992) found reduced CAl damage re-suiting from transient forebrain ischemia in rats pre treated with intraventricular injections of 7-chlo rokynurenic acid. However, in that global ischemia study, only rectal temperature was controlled. To our knowledge this is the first published report con cerning parenterally administered glycine receptor antagonists in models of cerebral ischemia.
Results from the current investigation are consis tent with several pools of data. Even if the quinox aline-2,3-dione derivatives were effective in reduc ing calcium influx through the NMDA ionophore by antagonism of glycine, no protection from global ischemia was observed, which has also repeatedly been the case for both competitive and noncompet itive antagonists of glutamate. In contrast, similar to numerous studies evaluating antagonism of glu tamate at the NMDA receptor, administration of glycine recognition site antagonists resulted in re duced infarct size and improved neurologic function as outcome measures of focal ischemic brain dam age. The data presented herein suggest that future studies with glycine receptor antagonists are war ranted; these may examine (a) the role of brain tem perature and (b) drug dosing schedules (particularly postischemic administration) in the context of focal cerebral ischemia.
